胸腺五肽纳米粒的制备及其处方优化
发布时间:2021-06-05
发布时间:2021-06-05
广东药学院学报
JournalofGuangdongPharmaceuticalUniversity
Aug.2012,28(4)
药剂学
胸腺五肽纳米粒的制备及其处方优化
单紫筠
1,2,3
11111,3,4
,谭银合,杨志文,余思琴,陈宝,吴传斌
(1.中山大学药学院,广东广州510006;2.广东药学院药科学院,广东广州510006;3.广东省创新药物制剂工程技术研究开发中心,广东广州510006;4.中山大学药物制剂工程研究开发中心,广东广州510006)
摘要:目的建立制备胸腺五肽纳米粒的方法并对其处方进行优化,为制备符合要求的压力定量吸入气雾剂奠定基础。方法将胸腺五肽、卵磷脂、乳糖溶于叔丁醇-水的混合溶剂中,冷冻干燥,将冻干产物用异丙离心除去多余的卵磷脂以得到纯药物纳米粒。采用星点设计-效应面法对其中水、卵磷脂、胸腺五醇混悬,
肽的用量进行优化,因胸腺五肽的含量受此处方影响不显著,所以只选取纳米粒的粒径、粒径分布为结果213.5卵磷脂∶叔丁醇、胸腺五肽∶水的比例分别为0.5(mL∶mL)、考察指标。结果最优处方:水∶叔丁醇、
(mg∶mL)、17.0(mg∶mL),即水的用量1.5mL、卵磷脂的用量640.57mg、胸腺五肽的用量25.57mg、叔丁醇的用量3.0mL。按此处方制备的纳米粒粒径在150nm左右,多分散系数为0.1以下,含量均能保持在98%以上。结论采用该方法制备胸腺五肽纳米粒,质量佳,重现性好,方法简便,具有良好的应用前景。关键词:胸腺五肽纳米粒;制备方法;处方优化;星点设计-效应面法中图分类号:TQ460.4;R94
文献标志码:A
doi:10.3969/j.issn.1006-8783.2012.04.001
8783(2012)04-0355-06文章编号:1006-
Anovelbottom-upprocesstoproducethymopentinnanoparticlesandtheirformulation
optimization
2,33,4
SHANZi-yun1,,TANYin-he1,YANGZhi-wen1,YUSi-qin1,CHENBao1,WUChuan-bin1,
(1.SchoolofPharmaceuticalScience,SunYat-SenUniversity,Guangzhou510006,China;2.SchoolofPharmacy,
GuangdongPharmaceuticalUniversity,Guangzhou510006,China;3.GuangdongResearchCenterforDrugDeliverySystems,Guangzhou510006,China;4.ResearchandDevelopmentCenterofPharmaceuticalEngineering,SunYat-senUniversity,Guangzhou510006,China)Abstract:ObjectiveAnovelbottom-upprocesswasdevelopedtoproducenanoparticlescontainingthymopentinandtheformulationwasoptimizedtoproducedesirablenanoparticlesfordevelopmentofpressedmetereddoseinhaler(pMDI)ofthymopentin(TP-5).MethodsAsolutionofTP-5,lecithinandlactoseintert-butylalcohol(TBA)/
waterco-solventsystemwasfreeze-driedtogeneratenanoparticlesandresiduallecithinwaswashedoffin
lyophilizatethroughcentrifugation.Formulationparameterssuchaslecithincontentinorganicphase,watercontentinTBA/waterco-solvent,andTP-5contentinwaterwereoptimizedwiththecentralcompositedesign-response
surfacemethodology.AstheretainedcontentofTP-5innanoparticlesdidnotsignificantlyvarywiththeabove
formulationparameters,onlyparticlesizeandsizedistributionofTP-5nanoparticleswastakenasresponseparameters.ResultsTheratiosofwatertoTBA,lecithintoTBAandTP-5towaterintheoptimumformulationwereseparately0.5(mL∶mL),213.5(mg∶mL),17.0(mg∶mL),bywhichTP-5nanoparticleswithabout150nmofthemeanparticlesizeand0.1ofpolydispersityindex(PI)andtheretainedcontentofTP-5above98%weregained.
ConclusionThenovelbottom-upprocesswasdemonstratedtoproduceTP-5nanoparticleswithprocesssimplicity
andconvenience,goodreproducibilityaswellashigh-productquality.Keywords:thymopentinnanoparticles;bottom-upprocess;formulationoptimization;centralcompositedesign-responsesurfacemethodology
收稿日期:2012-05-03
Email:damaoyu2012@126.com;通信作者:吴传斌(1963-),作者简介:单紫筠(1989-),女,硕士研究生,男,教授,博士生导
Email:cbwu2000@yahoo.com。师,主要从事药物缓控释及靶向释药技术的研究,
网络出版时间:2012-06-3022:11网络出版地址:http://www.cnki.net/kcms/detail/44.1413.R.20120630.2211.001.html
上一篇:麦当劳分析报告
下一篇:立式炉炉辊更换装置及更换方法